Overview Fundamentals API Earnings EOD API Sample Code Pricing

OBI Pharma (4174 TWO) stock market data APIs

NT$68.3 1.1(1.6%) as of October 22, 2024
Price chart is built with Anychart

OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor surface antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a Globo H monoclonal antibody; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898, OBI-998, and COVID-19 BCVax drugs. The company was founded in 2002 and is headquartered in Taipei, Taiwan.

OBI Pharma Financial Data Overview

67.2
68.3
-
68.3
66.4
58-92.9
15 474 M
231 M
58 046 K
-2.52
0.895
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '4174',
Type: 'Common Stock',
Name: 'OBI Pharma',
Exchange: 'TWO',
CurrencyCode: 'TWD',
CurrencyName: 'New Taiwan Dollar',
CurrencySymbol: 'NT$',
CountryName: 'Taiwan',
CountryISO: 'TW',
OpenFigi: NULL,
ISIN: 'TW0004174008',
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
}

OBI Pharma Fundamental Data is available in our Financial Data APIs

  • Net Revenue 58 046 K
  • EBITDA -2 063 065 984
  • Earnings Per Share -9.36
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get OBI Pharma Earnings via APIs

  • Latest Release 2023-03-13
  • EPS/Forecast NaN

Get OBI Pharma End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com